Vanguard Group’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.29M Buy
2025
Q1
$6.24M Buy
2024
Q4
$9.23M Buy
2024
Q3
$21.7K Hold
2024
Q2
$20.2K Hold
2024
Q1
$36.1K Sell
2023
Q4
$104K Sell
2023
Q3
$122K Sell
2023
Q2
$319K Sell
2023
Q1
$349K Hold
2022
Q4
$265K Buy
2022
Q3
$482K Hold
2022
Q2
$394K Hold
2022
Q1
$785K Buy
2021
Q4
$704K Hold
2021
Q3
$909K Buy
2021
Q2
$1.32M Buy